Literature DB >> 23162641

Biomarker expression in normal fimbriae: Comparison of high- and low-grade serous ovarian carcinoma.

Zhang Xuyin1, Ding Jingxin, Tao Xiang, Jia Luoqi, Hua Keqin.   

Abstract

The objective of this study was to assess the difference in fimbriae of high- and low-grade ovarian serous carcinoma (OSC). The fimbriae of normal appearance [without serous tubal intraepithelial carcinoma (STIC)] from 28 patients with high-grade OSCs and 24 patients with low-grade OSCs were assessed for the expression of 6 markers [E-cadherin, matrix metalloproteinase-2 (MMP-2), phospho-AKT (pAKT), cyclooxygenase-2 (COX-2), vascular endothelial growth factor (VEGF) and p53] using immunohistochemistry. Sectioning and extensively examining the fimbria (SEE-FIM) was performed to exclude fimbrial involvement for all the cases. The immunostaining levels of pAKT and COX-2 were significantly higher in the fimbriae of normal appearance from high-grade OSCs compared with low-grade OSCs (61 vs. 8% and 71 vs. 21%; P=0.005 and 0.007, respectively). The immunostaining of E-cadherin was significantly higher in the fimbriae of low-grade OSCs compared with high-grade OSCs (83 vs. 21%; P= 0.003). The remaining 3 markers (MMP-2, VEGF and p53) had similar expression in low- and high-grade OSCs (21 vs. 13%; 25 vs. 21%; and 14 vs. 8%; P=0.78, 0.86 and 0.82, respectively). Our results suggest marked biological differences in the behavior of the fimbriae in high- and low-grade OSCs and indicate that proliferation, cell adhesion and the inflammatory microenvironment of fimbriae in high-grade OSCs without STIC had changed prior to p53 mutation.

Entities:  

Year:  2012        PMID: 23162641      PMCID: PMC3499561          DOI: 10.3892/ol.2012.877

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  19 in total

1.  Preoperative serum vascular endothelial growth factor as a prognostic parameter in ovarian cancer.

Authors:  Lukas A Hefler; Robert Zeillinger; Christoph Grimm; Anil K Sood; Wen Fang Cheng; Angiolo Gadducci; Clemens B Tempfer; Alexander Reinthaller
Journal:  Gynecol Oncol       Date:  2006-06-05       Impact factor: 5.482

2.  Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship.

Authors:  David W Kindelberger; Yonghee Lee; Alexander Miron; Michelle S Hirsch; Colleen Feltmate; Fabiola Medeiros; Michael J Callahan; Elizabeth O Garner; Robert W Gordon; Chandler Birch; Ross S Berkowitz; Michael G Muto; Christopher P Crum
Journal:  Am J Surg Pathol       Date:  2007-02       Impact factor: 6.394

3.  Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role.

Authors:  K Vleminckx; L Vakaet; M Mareel; W Fiers; F van Roy
Journal:  Cell       Date:  1991-07-12       Impact factor: 41.582

4.  Prognostic factors in ovarian carcinoma stage III patients. Can biomarkers improve the prediction of short- and long-term survivors?

Authors:  J Kaern; M Aghmesheh; J M Nesland; H E Danielsen; B Sandstad; M Friedlander; C Tropé
Journal:  Int J Gynecol Cancer       Date:  2005 Nov-Dec       Impact factor: 3.437

5.  Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors.

Authors:  R T Burks; M E Sherman; R J Kurman
Journal:  Am J Surg Pathol       Date:  1996-11       Impact factor: 6.394

Review 6.  Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm.

Authors:  Robert J Kurman; Ie-Ming Shih
Journal:  Hum Pathol       Date:  2011-07       Impact factor: 3.466

7.  Preoperative serum vascular endothelial growth factor levels: significance in ovarian cancer.

Authors:  Brian C Cooper; Justine M Ritchie; Carrie L W Broghammer; Jeremy Coffin; Joel I Sorosky; Richard E Buller; Mary J C Hendrix; Anil K Sood
Journal:  Clin Cancer Res       Date:  2002-10       Impact factor: 12.531

8.  Expression of E-cadherin and beta-catenin in primary and peritoneal metastatic ovarian carcinoma.

Authors:  T Fujioka; Y Takebayashi; T Kihana; Y Kusanagi; K Hamada; H Ochi; T Uchida; M Fukumoto; M Ito
Journal:  Oncol Rep       Date:  2001 Mar-Apr       Impact factor: 3.906

Review 9.  Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis.

Authors:  Ie-Ming Shih; Robert J Kurman
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

Review 10.  Current overview of the role of Akt in cancer studies via applied immunohistochemistry.

Authors:  Viktor Shtilbans; Maoxin Wu; David E Burstein
Journal:  Ann Diagn Pathol       Date:  2008-04       Impact factor: 2.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.